Steady-state mycophenolate mofetil pharmacokinetic parameters enable prediction of systemic lupus erythematosus clinical flares: an observational cohort study

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1478-6354
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Steady-state mycophenolate mofetil pharmacokinetic parameters enable prediction of systemic lupus erythematosus clinical flares: an observational cohort study ; volume:12 ; number:6 ; day:22 ; month:12 ; year:2010 ; pages:1-7 ; date:12.2010
Arthritis Research & Therapy ; 12, Heft 6 (22.12.2010), 1-7, 12.2010

Urheber
Djabarouti, Sarah
Beteiligte Personen und Organisationen
Breilh, Dominique
Duffau, Pierre
Lazaro, Estibaliz
Greib, Carine
Caubet, Olivier
Saux, Marie-Claude
Pellegrin, Jean-Luc
Viallard, Jean-François
SpringerLink (Online service)

DOI
10.1186/ar3202
URN
urn:nbn:de:1111-2016050317520
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 08:49 UTC

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Djabarouti, Sarah
  • Breilh, Dominique
  • Duffau, Pierre
  • Lazaro, Estibaliz
  • Greib, Carine
  • Caubet, Olivier
  • Saux, Marie-Claude
  • Pellegrin, Jean-Luc
  • Viallard, Jean-François
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Autoimmune Ascites Responding to Mycophenolate Mofetil: A Case Report

Autoimmune Ascites Responding to Mycophenolate Mofetil: A Case Report

Mycophenolate mofetil use in refractory juvenile systemic lupus erythematosus

Mycophenolate mofetil use in refractory juvenile systemic lupus erythematosus

Mycophenolate Mofetil in severe or methotrexate refractory localized scleroderma

Mycophenolate Mofetil in severe or methotrexate refractory localized scleroderma

Is Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life?

Is Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life?

Sites of gastrointestinal lesion induced by mycophenolate mofetil: a comparison with enteric-coated mycophenolate sodium in rats

Sites of gastrointestinal lesion induced by mycophenolate mofetil: a comparison with enteric-coated mycophenolate sodium in rats

Mycophenolate mofetil in patients with refractory systemic autoimmune myopathies: case series

Mycophenolate mofetil in patients with refractory systemic autoimmune myopathies: case series

The effect of mycophenolate mofetil on podocytes in nephrotoxic serum nephritis

The effect of mycophenolate mofetil on podocytes in nephrotoxic serum nephritis

A placebo-controlled pilot study of intensification of antiretroviral therapy with mycophenolate mofetil

A placebo-controlled pilot study of intensification of antiretroviral therapy with mycophenolate mofetil

Mycophenolate mofetil inhibits the development of Coxsackie B3-virus-induced myocarditis in mice

Mycophenolate mofetil inhibits the development of Coxsackie B3-virus-induced myocarditis in mice

Effectiveness and safety of mycophenolate mofetil and rituximab combination therapy for immune idiopathic myopathies

Effectiveness and safety of mycophenolate mofetil and rituximab combination therapy for immune idiopathic myopathies

Efficacy and safety of mycophenolate mofetil treatment in IgA nephropathy: a systematic review

Efficacy and safety of mycophenolate mofetil treatment in IgA nephropathy: a systematic review

A randomized controlled trial of mycophenolate mofetil in patients with IgA nephropathy [ISRCTN62574616]

A randomized controlled trial of mycophenolate mofetil in patients with IgA nephropathy [ISRCTN62574616]

Verbundene Objekte